Structure

Physi-Chem Properties

Molecular Weight:  351.12
Volume:  347.377
LogP:  1.947
LogD:  1.853
LogS:  -2.959
# Rotatable Bonds:  2
TPSA:  93.45
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.849
Synthetic Accessibility Score:  4.238
Fsp3:  0.211
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.733
MDCK Permeability:  2.98191935144132e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.835
Plasma Protein Binding (PPB):  93.69380187988281%
Volume Distribution (VD):  1.773
Pgp-substrate:  6.478789329528809%

ADMET: Metabolism

CYP1A2-inhibitor:  0.317
CYP1A2-substrate:  0.112
CYP2C19-inhibitor:  0.425
CYP2C19-substrate:  0.631
CYP2C9-inhibitor:  0.646
CYP2C9-substrate:  0.274
CYP2D6-inhibitor:  0.047
CYP2D6-substrate:  0.165
CYP3A4-inhibitor:  0.712
CYP3A4-substrate:  0.858

ADMET: Excretion

Clearance (CL):  7.114
Half-life (T1/2):  0.515

ADMET: Toxicity

hERG Blockers:  0.1
Human Hepatotoxicity (H-HT):  0.277
Drug-inuced Liver Injury (DILI):  0.947
AMES Toxicity:  0.174
Rat Oral Acute Toxicity:  0.83
Maximum Recommended Daily Dose:  0.979
Skin Sensitization:  0.24
Carcinogencity:  0.943
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.639

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC487977

Natural Product ID:  NPC487977
Common Name*:   LTIOSJQYEGEEHY-BLVKFPJESA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  LTIOSJQYEGEEHY-BLVKFPJESA-N
Standard InCHI:  InChI=1S/C19H17N3O4/c1-12-15(23)21-19(25,11-13-7-3-2-4-8-13)18-20-16-14(17(24)22(12)18)9-5-6-10-26-16/h2-10,12,25H,11H2,1H3,(H,21,23)/t12-,19+/m1/s1
SMILES:  C[C@@H]1C(=N[C@](Cc2ccccc2)(c2nc3c(C=CC=CO3)c(=O)n12)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   44156271
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001346] Diazines
        • [CHEMONTID:0000075] Pyrimidines and pyrimidine derivatives
          • [CHEMONTID:0000291] Pyrimidones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10205 Aspergillus puniceus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[31095389]
NPO10205 Aspergillus puniceus Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1794 Individual Protein LXR-alpha Homo sapiens FC = 3.5 n.a. PMID[31095389]
NPT1794 Individual Protein LXR-alpha Homo sapiens EC50 = 47000.0 nM PMID[31095389]
NPT1210 Individual Protein T-cell protein-tyrosine phosphatase Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT205 Individual Protein Protein-tyrosine phosphatase 1C Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT206 Individual Protein Protein-tyrosine phosphatase 2C Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT3914 Individual Protein Tyrosine-protein phosphatase non-receptor type 9 Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT1078 Individual Protein Indoleamine 2,3-dioxygenase Homo sapiens IC50 = 14000.0 nM PMID[31095389]
NPT3655 Organism Cochliobolus australiensis Cochliobolus australiensis GI < 50.0 % PMID[31095389]
NPT562 Organism Colletotrichum gloeosporioides Colletotrichum gloeosporioides GI < 50.0 % PMID[31095389]
NPT637 Organism Fusarium oxysporum Fusarium oxysporum GI < 50.0 % PMID[31095389]
NPT826 Organism Magnaporthe oryzae Magnaporthe oryzae GI < 50.0 % PMID[31095389]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC487977 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC487977 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data